Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

TNXP

Insider Sentiment (TTM):

Last Purchase:2026-06-12Last Sale:-Shares Purchased (TTM):31,415Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:4,849,800Shares Outstanding:13,707,104Institutional Ownership Pct.:35.38%

Earnings Market Reaction:

Filing Date:2026-08-10Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	176	185	208	190	125	132	99	28	4	7	25	7
Accounts Receivable Net Current	12	9	6	3	2	3	4	4	3	-	-	-
F I F O Inventory Amount	5	4	6	6	6	8	8	-	-	-	-	-
Inventory Net	-	-	-	-	-	-	8	8	9	12	14	13
Receivables Net Current	-	-	-	-	-	-	-	-	-	-	-	2
Prepaid Expense And Other Assets Current	11	9	9	9	10	6	8	10	8	11	9	10
Assets Current	203	207	229	208	144	150	119	51	25	30	48	31
Property Plant And Equipment Net	45	45	44	43	42	42	42	43	43	93	94	95
Intangible Assets Net Excluding Goodwill	-	0	0	0	0	0	0	0	0	10	10	10
Goodwill	-	-	-	-	-	-	-	-	-	1	1	1
Operating Lease Right Of Use Asset	1	1	2	0	0	1	1	1	1	1	1	1
Other Assets Noncurrent	5	4	2	1	1	1	1	1	1	1	1	1
Assets	254	258	277	252	187	193	163	95	70	135	154	139
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	9	10	8	9	8	4	5	4	10	7	4	8
Accounts Payable And Other Accrued Liabilities Cur…	21	20	23	12	11	8	11	8	9	11	12	10
Long Term Debt Current	-	-	-	-	-	-	3	3	3	3	2	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	31	30	31	21	19	12	18	15	22	20	19	18
Long Term Debt Noncurrent	-	-	-	-	-	-	5	5	6	6	7	-
Operating Lease Liability Noncurrent	1	1	1	0	0	0	0	0	0	1	1	1
Liabilities Noncurrent
Derivative Liabilities Noncurrent	-	-	-	-	-	-	-	-	-	-	23	-
Liabilities	32	31	32	21	19	12	23	21	28	27	49	18
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,158	1,122	1,100	1,039	944	928	871	783	737	724	706	694
Retained Earnings Accumulated Deficit	-935	-895	-855	-808	-776	-748	-731	-709	-694	-616	-601	-573
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Stockholders Equity	222	227	245	231	168	180	140	74	42	108	106	121
Liabilities And Stockholders Equity	254	258	277	252	187	193	163	95	70	135	154	139
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	160	160
Common Stock Shares Issued	17	14	13	10	8	7	4	2	0	1	21	0
Shares Outstanding	17	14	13	10	8	7	4	2	3	1	21	0
Common Stock Capital Shares Reserved For Future Is…	-	-	0	-	-	-	-	-	-	-	0	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-21.55%	-12.54%	-29.06%	-	-	-	-	-	-	-	-	-
2025	111.83%	84.89%	103.28%	-40.98%	-46.63%	-58.59%	16.63%	-1.72%	2.38%	3.65%	1.42%	-8.05%
2024	-41.18%	-85.29%	-91.18%	-68.89%	-68.89%	-68.89%	28.57%	121.43%	207.14%	-17.78%	-8.28%	98.00%
2023	-	-	-	-	-	-	12.77%	-14.89%	-36.17%	-10.53%	-5.26%	-78.62%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	6.61	6.99	7.42	9.89	7.53	12.31	6.50	3.33	1.15	1.47	2.53	1.77
Quick Ratio	6.26	6.68	7.13	9.47	7.01	11.79	5.60	2.12	0.34	0.34	1.32	0.48
Working Capital	172.65M	177.52M	198.04M	187.04M	124.47M	137.43M	100.70M	35.36M	3.24M	9.62M	28.88M	13.60M
Leverage & Debt
Debt to Equity	0.14	0.14	0.13	0.09	0.12	0.07	0.17	0.28	0.67	0.25	0.46	0.15
Interest Coverage TTM	-1,858.71	-146.50	-121.81	-50.84	-37.84	-106.40	-110.69	-468.71	-154,143.00	-	-	-
Debt Ratio	0.13	0.12	0.12	0.08	0.10	0.06	0.14	0.22	0.40	0.20	0.32	0.13
Efficiency & Turnover
Asset Turnover TTM	0.13	0.08	0.06	0.06	0.08	0.06	0.06	0.10	0.11	0.07	0.04	0.02
Days Sales Outstanding TTM	88.58	126.12	138.60	132.79	105.05	120.39	133.18	90.11	97.83	-	-	142.93
Receivables Turnover TTM	4.12	2.89	2.63	2.75	3.47	3.03	2.74	4.05	3.73	-	-	2.55
Per Share Metrics
Diluted EPS TTM	-9.60	-10.75	-14.57	-11.12	-11.11	-22.26	-176.60	-215.82	-3,633.46	-3,535.54	-14.72	-17,630.04
Free Cash Flow Per Share TTM	-9.50	-9.53	-12.13	-8.55	-8.92	-10.11	-82.90	-110.41	-1,842.87	-3,258.66	-13.87	-15,754.43
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	83.83%	58.56%	49.34%	34.31%	29.27%	29.81%	23.07%	20.74%	21.59%	-	-	-
Operating Profit Margin TTM	-568.43%	-861.16%	-959.05%	-969.97%	-838.00%	-1,308.67%	-1,354.28%	-1,253.65%	-1,237.30%	-1,032.48%	-1,523.94%	-3,103.01%
Net Profit Margin TTM	-548.64%	-839.52%	-946.22%	-963.38%	-828.22%	-1,313.87%	-1,288.25%	-1,197.86%	-1,196.11%	-961.87%	-1,501.78%	-3,200.68%
Growth Metrics
Net Revenue Growth (1Y)	196.02%	74.84%	29.85%	-8.79%	-21.09%	-2.04%	29.94%	183.05%	-	-	-	-
Net Income Growth (1Y)	96.10%	11.72%	-4.63%	-26.64%	-45.36%	33.81%	11.47%	5.93%	15.80%	-20.15%	-0.19%	18.12%
EPS Growth (1Y)	-13.63%	-51.69%	-91.75%	-94.85%	-99.69%	-99.37%	1,099.69%	-98.78%	-83.73%	194.05%	-99.26%	1,016.13%
Valuation Metrics
P/E TTM	-1.33	-1.28	-1.07	-2.17	-3.24	-0.80	-0.19	-0.07	-0.02	-0.17	-86.96	-0.10
P/B TTM	0.95	0.83	0.54	0.93	1.57	0.59	0.17	0.13	0.07	0.16	96.13	0.11
P/S TTM	7.29	10.74	10.14	20.93	26.82	10.55	2.41	0.83	0.23	1.65	1,305.87	3.20
Market Cap	212.27M	188.47M	132.95M	215.57M	263.63M	105.98M	24.30M	9.40M	2.87M	16.95M	10.14B	12.75M
Enterprise Value	35.65M	2.46M	-76.86M	24.23M	137.40M	-26.64M	-25.75M	-11.74M	6.30M	17.98M	10.13B	4.83M
Calculated Values
Free Cash Flow TTM	-158.11M	-130.64M	-103.21M	-76.32M	-65.39M	-59.95M	-61.05M	-69.19M	-75.58M	-90.87M	-109.90M	-114.09M
Net Debt	-176.62M	-186.01M	-209.81M	-191.35M	-126.24M	-132.62M	-50.05M	-21.14M	3.43M	1.03M	-16.94M	-7.92M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-12Purchase

Owner: Taylor, Carolyn E.

Title: -

Shares: 1,415

Price/Share: $10.55

Value: $14,928.25

Shares Owned: 1,833

Relationship: Director

Ownership: Direct

2026-06-09Purchase

Owner: Lederman, Seth

Title: Chief Executive Officer

Shares: 5,000

Price/Share: $11.79

Value: $58,950.00

Shares Owned: 9,005

Relationship: Director,Officer

Ownership: Direct

2026-06-08Purchase

Owner: Stillwell, Richard Newcom…

Title: -

Shares: 5,000

Price/Share: $11.65

Value: $58,250.00

Shares Owned: 5,000

Relationship: Director

Ownership: Direct

2026-03-31Purchase

Owner: Lederman, Seth

Title: Chief Executive Officer

Shares: 5,000

Price/Share: $12.62

Value: $63,100.00

Shares Owned: 20,001

Relationship: Director,Officer

Ownership: Indirect

2026-03-18Purchase

Owner: Lederman, Seth

Title: Chief Executive Officer

Shares: 15,000

Price/Share: $14.89

Value: $223,350.00

Shares Owned: 15,001

Relationship: Director,Officer

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-12	Taylor, Carolyn E.	Director	-	Direct	Purchase	1,415	10.55	$14,928.25	1,833	4
2026-06-09	Lederman, Seth	Director,Officer	Chief Executive Officer	Direct	Purchase	5,000	11.79	$58,950.00	9,005	4
2026-06-08	Stillwell, Richard Newcom…	Director	-	Direct	Purchase	5,000	11.65	$58,250.00	5,000	4
2026-03-31	Lederman, Seth	Director,Officer	Chief Executive Officer	Indirect	Purchase	5,000	12.62	$63,100.00	20,001	4
2026-03-18	Lederman, Seth	Director,Officer	Chief Executive Officer	Indirect	Purchase	15,000	14.89	$223,350.00	15,001	4
2025-08-21	Taylor, Carolyn E.	Director	-	Direct	Purchase	418	36.03	$15,060.54	418	4
2025-08-20	Treco, James	Director	-	Direct	Purchase	250	36.00	$9,000.00	250	4
2025-05-15	Lederman, Seth	Director,Officer	Chief Executive Officer	Direct	Purchase	4,000	21.55	$86,200.00	4,005	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

35.38%

Inst. Shares: 4,849,800

Shares Outstanding: 13,707,104

2025-12-31

43.84%

Inst. Shares: 3,731,245

Shares Outstanding: 8,511,318

2025-09-30

26.37%

Inst. Shares: 2,353,240

Shares Outstanding: 8,922,792

2025-06-30

18.71%

Inst. Shares: 1,370,569

Shares Outstanding: 7,327,257

2025-03-31

7.23%

Inst. Shares: 428,713

Shares Outstanding: 5,927,231

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	4,849,800	13,707,104	35.38%
2025-12-31	3,731,245	8,511,318	43.84%
2025-09-30	2,353,240	8,922,792	26.37%
2025-06-30	1,370,569	7,327,257	18.71%
2025-03-31	428,713	5,927,231	7.23%
2024-12-31	14,432,215	736,339	-
2024-09-30	848,719	626,669	135.43%
2024-06-30	248,303	41,011	-
2024-03-31	11,519,857	27,886	-
2023-12-31	14,081,773	7,925,000	177.69%
2023-09-30	3,367,943	7,242	-
2023-06-30	733,337	5,760	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Tonix Pharmaceuticals Holding Corp. (TNXP) — SEC Financial Statements & Analysis

Tonix Pharmaceuticals Holding Corp. (TNXP) is a pharmaceutical preparations company, incorporated in NV. Tonix Pharmaceuticals Holding Corp. trades on Nasdaq as: TNXP. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Tonix Pharmaceuticals Holding Corp. reported a 196.02% year-over-year revenue growth, a Gross Profit Margin of 83.83% (TTM), a Debt-to-Equity ratio of 0.14x, a Price-to-Sales (P/S) ratio of 7.29x (TTM), a Price-to-Book (P/B) ratio of 0.95x (TTM), at a market cap of $212.27M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 196.02%
Gross Profit Margin TTM: 83.83%
Debt To Equity: 0.14x
P/S TTM: 7.29x
P/B TTM: 0.95x
Market Cap: $212.27M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Tonix Pharmaceuticals Holding Corp. in?

Tonix Pharmaceuticals Holding Corp. (TNXP) operates in the Pharmaceutical Preparations industry.

What is TNXP's market cap?

Tonix Pharmaceuticals Holding Corp. (TNXP) has a market capitalization of $212.27M as of 2026-06-30.

What exchange does TNXP trade on?

Tonix Pharmaceuticals Holding Corp. (TNXP) trades on the Nasdaq.

Where is Tonix Pharmaceuticals Holding Corp. incorporated?

Tonix Pharmaceuticals Holding Corp. is incorporated in NV.